Branded

WOONSOCKET, R.I. — CVS Pharmacy added Arizona, Georgia, Iowa and South Carolina to the list of stated where it now dispenses the opioid overdoes reversal drug naloxone to patients without a prescription. CVS Pharmacy locations in 41 states are now able to increase access to this medication.

NEW YORK — Genentech, Publix, Mars and Regeneron Pharmaceuticals were named to Fortune magazine’s 100 Best Companies to Work For list. The listings are based upon reviews by company employees.

WASHINGTON — The U.S. Food and Drug Administration approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night). Noctiva is the first FDA-approved treatment for this condition.

Noctiva is marketed by Renaissance Lakewood for Serenity Pharmaceuticals.

WASHINGTON — Reps. Doug Collins, R-Ga., and Dave Loebsack, D-Iowa, on Thursday introduced H.R. 1316, the Prescription Drug Price Transparency Act, to protect taxpayers and the community pharmacists who serve them by requiring greater transparency from pharmacy benefit managers.

WASHINGTON — The U.S. Food and Drug Administration approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced nasal inflammation (allergic rhinitis), with or without eye inflammation (conjunctivitis), in people 18 through 65 years of age.

WASHINGTON — The U.S. Food and Drug Administration approved Lexicon Pharmaceuticals’ Xermelo (telotristat ethyl) tablets in combination with somatostatin analog therapy for the treatment of adults with carcinoid syndrome diarrhea that SSA therapy alone has inadequately controlled.